pharma.markets

  • HOME
  • Imprint

institut

Spike-Protein on SARS-CoV-2 (Source: S.Myshkovsky/photodisc/Gettyimages)

Paul-Ehrlich-Institut – Another Clinical Trial of a COVID-19 Vaccine authorised in Germany

20/06/2020 MaP 0

The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, has authorised another clinical trial of a vaccine against COVID-19 in Germany. The intensive preliminary scientific advice […]

RECOVER – the Paul-Ehrlich-Institut Authorises another COVID-19 Therapy Study with Reconvalescent Plasma

02/06/2020 MaP 0

The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines has authorised the second clinical study with COVID-19 reconvalescent plasma (RECOVER) in Germany. The purpose of such […]

Warning against the Off label Use of BCG Products

26/05/2020 MaP 0

In Germany, immunostimulatory products on the basis of bacteria preparations derived from the Bacillus Calmette-Guérin (BCG) mycobacterial strain are authorised for the treatment of urinary […]

Paul-Ehrlich Institut : First Clinical Trial of a COVID-19 Vaccine Authorised in Germany

22/04/2020 MaP 0

The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, has authorised the first clinical trial of a vaccine against COVID-19 in Germany. Spike-Protein SARS-CoV-2 (Source: Viaframe/Corbis/GettyImages) […]

Fondation PSA provides exceptional support to “All United Against Coronavirus” alliance of Fondation de France, AP-HP and Institut Pasteur

08/04/2020 MaP 0

• Mobilization for Covid-19 emergency aid, of all the funds allocated to the 2020 calls for projects of Fondation PSA • This donation will support […]

Translation

en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianja Japaneseko Koreanpt Portugueseru Russianes Spanish

Search

Categories

  • Age.related Degeneration
  • Animal health
  • Asthma
  • Cancer
  • COVID-19
  • EIB
  • EU
  • FCPA Investigations
  • FDA
  • Finance
  • Humanitarian Aid
  • Imprint
  • Influenza
  • MS
  • News
  • Research
  • Rheumatology
  • Space Science
  • UN
  • Vaccines

Reports

  • Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of Medicine
  • Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
  • EU doubles contribution to COVAX to €1 billion to ensure safe and effective vaccines for low and middle-income countries
  • In Vitro Study Published in The New England Journal of Medicine
  • Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®

Archive

  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
  • Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of Medicine

    25/02/2021 0
  • Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants

    25/02/2021 0
  • Copyright European Commission 2021

    EU doubles contribution to COVAX to €1 billion to ensure safe and effective vaccines for low and middle-income countries

    20/02/2021 0
  • In Vitro Study Published in The New England Journal of Medicine

    17/02/2021 0
  • Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®

    17/02/2021 0
Archives
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
TAGS
affected africa aid biontech cancer commission companies coronavirus covid-19 covid19 crisis economy elpais.com eu europe european fda fight food global guarantee health hygiene italy links medical merck novartis pandemic pfizer production products recommendations region response roche safety scheme sector spain state statistics stats support vaccine

Copyright © 2021 | WordPress Theme by MH Themes